Holen Sie sich die Stockscreener-App
7.84
0.51%
0.04
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
8.18%
52.70
|
48.72 | 50.13 | 38.87 | 36.04 |
| Costs And Expenses |
7.17%
62.40
|
58.23 | 59.58 | 47.09 | 43.24 |
| Depreciation and Amortization |
0.17%
0.599
|
0.598 | 0.581 | 0.562 | 0.529 |
| Operating Income/Loss |
7.17%
-62.40
|
-58.23 | -59.58 | -47.09 | -43.24 |
| Nonoperating Income/Loss |
5.00%
4.056
|
3.863 | 4.198 | 3.009 | 4.65 |
| Income/Loss From Continuing Operations Before Tax |
7.33%
-58.35
|
-54.37 | -59.58 | -44.08 | -38.59 |
| Income/Loss From Continuing Operations After Tax |
7.33%
-58.35
|
-54.37 | -55.38 | -44.08 | -38.59 |
Net Income/Loss
|
7.33%
-58.35
|
-54.37 | -55.38 | -44.08 | -38.59 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,878%
94.80
|
2.3834 | 86.17 | 74.75 | 70.73 |
| Diluted Average Shares |
3,878%
94.80
|
2.3834 | 86.17 | 74.75 | 70.73 |
| Basic Earnings Per Share |
1.59%
-0.62
|
-0.63 | -0.64 | -0.59 | -0.55 |
| Diluted Earnings Per Share |
1.59%
-0.62
|
-0.63 | -0.64 | -0.59 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):